跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 35,256 条关于
“DNA Topoisomerase I”
全部
35,256
临床试验
25,339
药物
1,406
机构
170
资讯
8,341
11个月前
Henlius' PD-L1 ADC HLX43 Receives FDA Orphan Drug Designation for Thymic Epithelial Tumors
去年
Mabwell's CDH17-Targeting ADC 7MW4911 Receives Dual IND Acceptance from FDA and NMPA
8个月前
Whitehawk Therapeutics Advances Two Next-Generation ADCs into Clinical Trials with FDA IND Clearances
去年
Hansoh Pharma's HS-20093 ADC Granted Breakthrough Therapy Designation for SCLC in China
去年
SHR-A1921 Shows Promise in Platinum-Resistant Ovarian Cancer
2年前
FDA Grants Fast Track Designation to BNT325/DB-1305 for Platinum-Resistant Ovarian Cancer
去年
Henlius Advances World's First PD-L1 ADC to Phase 2 Trial for Advanced NSCLC Treatment
上个月
Advanced Endometrial Cancer Pipeline Gains Momentum as ADCs, Immunotherapy and Targeted Combinations Reshape Treatment
9个月前
University of Hawaii Researchers Identify Strategy to Overcome Antibody-Drug Conjugate Resistance in Breast Cancer
9个月前
Robust AML Clinical Pipeline Shows Promise with 100+ Companies Developing Novel Therapies
第 1 页,共 835 页
上一页
下一页